Codexis, Inc. (CDXS)
CDXS moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How CDXS actually reacts to news — the realized, point-in-time move the market made, measured across 267 labeled events over the last three years with zero look-ahead.
CDXS’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | +0.23% | 52% | 267 |
| 30-min | 0.00% | 51% | 267 |
| 60-min | +0.10% | 52% | 267 |
| to close | 0.00% | 45% | 265 |
| Middle 50% of CDXS reactions | -1.35% to +1.67% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 267 |
Half of all Codexis, Inc. news events land between -1.35% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How CDXS reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 12 | -1.26% | 17% | +0.44% |
| Analyst downgrades | 12 | +0.44% | 58% | +2.96% |
| Rating reiterations | 19 | -0.23% | 32% | 0.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how CDXS ranks against every other measured name →
That’s how CDXS usually reacts — get an email when it moves on news →Email me when CDXS moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to CDXS's baseline. Nothing else.
Recent CDXS events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA | Press release | GlobeNewswire | +1.15% | +3.82% | |
| Codexis to Participate in Cantor Global Healthcare Conference 2026 | Press release | GlobeNewswire | -1.22% | +1.22% | |
| Codexis Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.00% | +7.38% | |
| Form 10-Q CODEXIS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +7.38% | |
| Form 8-K CODEXIS, INC. For: Aug 11 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +7.38% | |
| Codexis Appoints David Butler, PhD, to Strategic Advisory Board | Press release | GlobeNewswire | +0.36% | +3.57% | |
| Codexis to Report Second Quarter 2026 Financial Results on August 11 | Press release | GlobeNewswire | +1.06% | -0.66% | |
| Form 8-K CODEXIS, INC. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +1.06% | -0.66% | |
| Codexis Announces Pricing of Public Offering of Common Stock | Press release | GlobeNewswire | +3.04% | +0.00% | |
| Codexis Announces Proposed Public Offering of Common Stock | Press release | GlobeNewswire | +3.04% | +0.00% | |
| Form 8-K CODEXIS, INC. For: Jul 23 | SEC filing · Form 8-K | SEC EDGAR | +3.04% | +0.00% | |
| Form 8-K CODEXIS, INC. For: Jun 17 | SEC filing · Form 8-K | SEC EDGAR | -0.92% | -8.85% | |
| Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA | Press release | GlobeNewswire | -2.03% | +4.88% | |
| Codexis Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +4.42% | +9.62% | |
| Form 10-Q CODEXIS, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +4.42% | +9.62% | |
| Form 8-K CODEXIS, INC. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +4.42% | +9.62% | |
| Codexis to share RNA manufacturing advances at TIDES USA | Press release | GlobeNewswire | -1.42% | +0.00% | |
| Form ARS CODEXIS, INC. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -1.42% | +0.00% | |
| Form DEF 14A CODEXIS, INC. For: Jun 17 | SEC filing · Form DEF | SEC EDGAR | -1.42% | +0.00% | |
| Form DEFA14A CODEXIS, INC. | SEC filing · Form DEFA14A | SEC EDGAR | -1.42% | +0.00% | |
| Codexis to Report First Quarter 2026 Financial Results on May 7 | Press release | GlobeNewswire | -1.22% | +2.44% | |
| Form 8-K CODEXIS, INC. For: Apr 08 | SEC filing · Form 8-K | SEC EDGAR | +0.84% | +3.80% | |
| Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results | Press release | GlobeNewswire | +5.30% | -9.52% | |
| Form 10-K CODEXIS, INC. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +5.30% | -9.52% | |
| Form 8-K CODEXIS, INC. For: Mar 11 | SEC filing · Form 8-K | SEC EDGAR | +5.30% | -9.52% | |
| Codexis signs agreement to manufacture 50 g siRNA using its ECO Synthesis® Manufacturing Platform | Press release | PR Newswire | +2.26% | +11.51% | |
| Codexis to Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 11 | Press release | GlobeNewswire | +1.34% | +0.00% | |
| Codexis to Participate in TD Cowen 46th Annual Health Care Conference | Press release | GlobeNewswire | +1.67% | +0.83% | |
| Codexis Achieves ISO 9001:2015 Certification | Press release | GlobeNewswire | +1.55% | -3.10% | |
| Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics | Press release | PR Newswire | +0.29% | -1.16% | |
| Codexis Announces Signing of Lease for GMP Manufacturing Facility | Press release | GlobeNewswire | +0.29% | +1.16% | |
| Codexis Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +4.06% | +2.42% | |
| Form 10-Q CODEXIS, INC. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +4.06% | +2.42% | |
| Form 8-K CODEXIS, INC. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | +4.06% | +2.42% | |
| Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing | Press release | PR Newswire | -0.20% | -4.72% | |
| Codexis to Report Third Quarter 2025 Financial Results on November 6 | Press release | GlobeNewswire | +0.39% | +0.78% | |
| Codexis to Participate in Cantor Global Healthcare Conference | Press release | GlobeNewswire | +0.75% | +1.49% | |
| Codexis Reports Second Quarter 2025 Financial Results | Press release | GlobeNewswire | +8.97% | -8.82% | |
| Form 10-Q CODEXIS, INC. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +8.97% | -8.82% | |
| Form 8-K CODEXIS, INC. For: Aug 13 | SEC filing · Form 8-K | SEC EDGAR | +8.97% | -8.82% | |
| Form S-8 CODEXIS, INC. | SEC filing · Form S-8 | SEC EDGAR | +8.97% | -8.82% | |
| Codexis to Report Second Quarter 2025 Financial Results on August 13 | Press release | GlobeNewswire | -0.37% | -1.83% | |
| Form 8-K CODEXIS, INC. For: Jun 10 | SEC filing · Form 8-K | SEC EDGAR | -0.85% | -3.85% | |
| Codexis’ Landmark Presentations at TIDES USA Highlight Reproducibility and Process Simplification of the ECO Synthesis Platform for Manufacturing siRNA | Press release | GlobeNewswire | +1.30% | +6.49% | |
| Codexis to Participate in Jefferies Global Healthcare Conference | Press release | GlobeNewswire | +1.30% | +6.49% | |
| Codexis Reports First Quarter 2025 Financial Results | Press release | GlobeNewswire | -10.81% | +13.06% | |
| Form 10-Q CODEXIS, INC. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -10.81% | +13.06% | |
| Form 8-K CODEXIS, INC. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | -10.81% | +13.06% | |
| Codexis Announces Six Presentations Featuring the ECO Synthesis Platform at TIDES USA Annual Meeting | Press release | GlobeNewswire | +0.89% | +1.33% | |
| Codexis to Report First Quarter 2025 Financial Results on May 14 | Press release | GlobeNewswire | -2.58% | -0.43% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the CDXS section they belong to.
Where else CDXS is measured.
CDXS earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Verrica Pharmaceuticals Inc. (VRCA) | 269 | -0.01% | 46% |
| CONMED Corporation (CNMD) | 268 | -0.11% | 47% |
| CytomX Therapeutics, Inc. (CTMX) | 267 | 0.00% | 44% |
| Galapagos NV - American Depositary Shares (GLPG) | 267 | -0.05% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Codexis, Inc.'s median reaction calculated?
Every labeled CDXS news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 267 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of CDXS's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does CDXS's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.